BioHarvest Sciences Revenue 2020-2024 | BHST

BioHarvest Sciences revenue from 2020 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
BioHarvest Sciences Annual Revenue
(Millions of US $)
2023 $13
2022 $5
2021 $2
2020 $0
2019 $0
2019 $
2018 $
BioHarvest Sciences Quarterly Revenue
(Millions of US $)
2024-06-30 $6
2024-03-31 $5
2023-12-31 $5
2023-09-30 $3
2023-06-30 $3
2023-03-31 $2
2022-12-31 $2
2022-09-30 $2
2022-06-30 $1
2022-03-31 $1
2021-12-31 $1
2021-09-30 $1
2021-06-30 $0
2021-03-31 $0
2020-12-31 $0
2020-09-30 $0
2020-06-30 $0
2020-03-31 $0
2019-12-31
2019-09-30 $0
2019-06-30 $0
2019-03-31
Sector Industry Market Cap Revenue
Medical MED-BIOMED/GENE $0.098B $0.013B
BioHarvest Sciences Inc. is a biotech firm. It focused on leveraging its botanical synthesis technology to develop science-based and clinically proven therapeutic solutions, within business verticals nutraceutical health and wellness products such as dietary supplements and development of plant cell-based Active Pharmaceutical Ingredients which focus on specific medical indications. BioHarvest Sciences Inc. is based in Vancouver, Canada.
Stock Name Country Market Cap PE Ratio
Primo Water (PRMB) United States $4.535B 35.81
P.A.M Transportation Services (PAMT) United States $0.430B 0.00
Rigetti Computing (RGTI) United States $0.325B 0.00
Alpha Cognition (ACOG) Canada $0.035B 0.00
Atlantic Coastal Acquisition II (ABP) United States $0.000B 0.00